CytoReason vs Pharmmies
CytoReason vs Pharmmies, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Pharmmies on 35/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 35/100
- headcount: 116 against 2
- LinkedIn following: 12,830 against 259
Pharmmies
- agent readiness: 49/100 against 21/100
At a glance
| Measure | CytoReason | Pharmmies |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Pharmmies is a pharmaceutical startup focused on improving pediatric medication delivery through innovative formulations. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Pharmaceutical, HealthTech, MedTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Pharmaceuticals |
| Founded | 2016 | 2021 |
| Headquarters | Tel Aviv, Israel | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | CytoReason | Pharmmies |
|---|---|---|
| Employees | 116 | 2 |
| Headcount growthLast 12 months | +13.7% | Not published |
| Total funding | $128M | Not published |
| Latest round | Series B | Not published |
| LinkedIn followers | 12,830 | 259 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Pharmmies |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 35/100 |
| Traction | 60/100 | 5/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 30/100 | 31/100 |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (49/100) |
| Domain ratingLink authority, 0-100 | 40/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Pharmmies |
|---|---|---|
| Analytics | Segment | Google Analytics 4 |
| Open source | No | Yes |
CytoReason vs Pharmmies: common questions
Which is better, CytoReason or Pharmmies?
On our 0-100 score CytoReason rates higher (68/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do CytoReason and Pharmmies compare on the numbers?
CytoReason leads on our overall score (68/100 against 35/100), headcount (116 against 2), LinkedIn following (12,830 against 259). Pharmmies leads on agent readiness (49/100 against 21/100).
Read the full CytoReason review and pricing or the Pharmmies review and pricing. You can also browse other CytoReason alternatives we track.